Armata Pharmaceuticals, Inc.
Developing bacteriophage therapeutics for antibiotic-resistant infections.
ARMP | NYSE
Overview
Corporate Details
- ISIN(s):
- US04216R1023
- LEI:
- Country:
- United States of America
- Address:
- 5005 MCCONNELL AVE, 90066 LOS ANGELES
- Website:
- https://www.armatapharma.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company focuses on creating precisely targeted treatments for multi-drug resistant and difficult-to-treat bacterial infections. Armata is advancing a pipeline of both natural and synthetic phage candidates, aiming to provide innovative solutions where conventional antibiotics have failed.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Armata Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Armata Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Armata Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
